Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependant on clopidogrel response

Thrombosis Research

Volumn 130, Issue 2, 2012, Pages 198-202

  Kreutz, Rolf P ^a,b   Breall, Jeffrey A ^a   Kreutz, Yvonne ^b   Owens, Janelle ^b   Lu, Deshun ^b   Bolad, Islam ^a   Von Der Lohe, Elisabeth ^a   Sinha, Anjan ^a   Flockhart, David A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aggregation; clopidogrel; Platelet; thrombin

Indexed keywords

CLOPIDOGREL; CYTOCHROME P450 2C19; GENOMIC DNA; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; AGED; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENOTYPE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

EID: 84864409943     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.02.049     Document Type: Article

References (33)

1. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, and T.A. Bass Variability in individual responsiveness to clopidogrel: clinical implication, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516 (Pubitemid 46517957)
2. P.A. Gurbel, K.P. Bliden, K. Guyer, P.W. Cho, K.A. Zaman, and R.P. Kreutz Platelet Reactivity in Patients and Recurrent Events Post-Stenting: Results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 10 2005 1820 1826 (Pubitemid 41579802)
3. P. Buonamici, R. Marcucci, A. Migliorini, G.F. Gensini, A. Santini, and R. Paniccia Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2007 2312 2317 (Pubitemid 46891710)
4. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, and E.T. Bal Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation JAMA 303 2010 754 762
5. D. Trenk, W. Hochholzer, M.F. Fromm, L.E. Chialda, A. Pahl, and C.M. Valina Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents J Am Coll Cardiol 51 2008 1925 1934 (Pubitemid 351636443)
6. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, and J.T. Brandt Cytochrome P-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
7. J.P. Collet, J.S. Hulot, A. Pena, E. Villard, J.B. Esteve, and J. Silvain Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Lancet 373 2009 309 317
8. T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, and N. Méneveau French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
9. J.L. Mega, T. Simon, J.P. Collet, J.L. Anderson, E.M. Antman, and K. Bliden Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JAMA 304 2010 1821 1830
10. J.I. Borissoff, H.M. Spronk, and H. ten Cate The hemostatic system as a modulator of atherosclerosis N Engl J Med 364 2011 1746 1760
11. M.L. Kahn, Y.W. Zheng, W. Huang, V. Bigornia, D. Zeng, and S. Moff A dual thrombin receptor system for platelet activation Nature 394 1998 690 694 (Pubitemid 28389797)
12. T.K. Vu, D.T. Hung, V.I. Wheaton, and S.R. Coughlin Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation Cell 64 1991 1057 1068 (Pubitemid 121001193)
13. W.F. Xu, H. Andersen, T.E. Whitmore, S.R. Presnell, D.P. Yee, and A. Ching Cloning and characterization of human protease-activated receptor 4 Proc Natl Acad Sci U S A 95 1998 6642 6646 (Pubitemid 28278033)
14. H. Andersen, D.L. Greenberg, K. Fujikawa, W. Xu, D.W. Chung, and E.W. Davie Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity Proc Natl Acad Sci U S A 96 20 1999 11189 11193 (Pubitemid 29487356)
15. C. Trumel, B. Payrastre, M. Plantavid, B. Hechler, C. Viala, and P. Presek A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase Blood 94 12 1999 4156 4165
16. J.A. Jakubowski, D.C. Payne, Y.G. Li, J.T. Brandt, D.S. Small, and N.A. Farid The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration Thromb Haemost 99 2008 409 415 (Pubitemid 351230973)
17. D. Angiolillo, and P. Capranzano Pharmacology of emerging novel platelet inhibitors Am Heart J 156 2008 S10 S15
18. P. Tricoci, Z. Huang, C. Held, D.J. Moliterno, P.W. Armstrong, and F. Van de Werf Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes N Engl J Med 2011 [published online November 13, 2011]
19. M.L. O'Donoghue, D.L. Bhatt, S.D. Wiviott, S.G. Goodman, D.J. Fitzgerald, and D.J. Angiolillo Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin-Acute Coronary Syndromes Trial Circulation 123 17 2011 1843 1853
20. R.P. Kreutz, U.S. Tantry, K.P. Bliden, and P.A. Gurbel Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists Blood Coagul Fibrinolysis 18 2007 713 718 (Pubitemid 350059328)
21. R.P. Kreutz, M. Alloosh, K. Mansour, Z. Neeb, Y. Kreutz, and D.A. Flockhart Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity Diabetes Metab Syndr Obes 4 2011 99 105
22. L.K. Jennings, and M. McCabe-White Platelet Aggregation A.D. Michelson, Platelets 2007 Elsevier Oxford, UK 503
23. T. Gremmel, A. Calatzis, S. Steiner, A. Kaider, D. Seidinger, and R. Koppensteiner Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel Platelets 21 7 2010 515 521
24. www.hapmap.org accessed Jan 31st, 2012
25. A.R. Shuldiner, J.R. O'Connell, K.P. Bliden, A. Gandhi, K. Ryan, and R.B. Horenstein Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clincal efficacy of clopidogrel JAMA 302 2009 849 858
26. O. Rideg, A. Komócsi, T. Magyarlaki, M. Tokés-Füzesi, A. Miseta, and G.L. Kovács Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention Pharmacogenomics 12 9 2011 1269 1280
27. H. Haberstock-Debic, P. Andre, S. Mills, D.R. Phillips, and P.B. Conley A Clopidogrel-Insensitive Inducible Pool of P2Y12 Receptors Contributes to Thrombus Formation: Inhibition by Elinogrel, a Direct-Acting, Reversible P2Y12 Antagonist J Pharmacol Exp Ther 339 2011 54 61
28. D. Sibbing, O. von Beckerath, A. Schömig, A. Kastrati, and N. von Beckerath Platelet function in clopidogrel-treated patients with acute coronary syndrome Blood Coagul Fibrinolysis 18 2007 335 339 (Pubitemid 46699410)
29. D.A. Walz, G.F. Anderson, R.E. Ciaglowski, M. Aiken, and J.W. Fenton Thrombin elicited contractile responses of aortic smooth muscle Proc Soc Exp Biol Med 180 1985 518 526 (Pubitemid 16139525)
30. I. Cornelissen, D. Palmer, T. David, L. Wilsbacher, C. Concengo, and P. Conley Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis Proc Natl Acad Sci U S A 107 43 2010 18605 18610
31. S. Nylander, C. Mattsson, S. Ramström, and T.L. Lindahl Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation Br J Pharmacol 142 2004 1325 1331 (Pubitemid 39178886)
32. P. Van der Meijden, M. Feijge, P. Giesen, M. Huijberts, L. van Raak, and J. Heemskerk Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk Thromb Haemost 93 2005 1010 1201
33. H. Shankar, A. Garcia, J. Prabhakar, S. Kim, and S.P. Kunapuli P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation J Thromb Haemost 4 2006 638 647